Mangoceuticals, Inc.
MGRX· Nasdaq
MGRXMangoceuticals, Inc.
Filed Mar 20, 2025 · 10-K · 79 days after period end · 0001641172-25-000085
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|
| Revenue | $105.25K | $244.37K | — |
| Net Income | -$1.95M | -$2.57M | -$673.36K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mangoceuticals, Inc. · CIK 1938046 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Mar 20, 2025 · 79 d after period end
